Attention-Deficit/Hyperactivity Disorder
77
7
8
52
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
22 trials with published results (29%)
Research Maturity
52 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.5%
5 terminated out of 77 trials
91.2%
+4.7% vs benchmark
35%
27 trials in Phase 3/4
42%
22 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 52 completed trials
Clinical Trials (77)
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adolescents
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
A Pilot Study of a Remote ADHD Monitoring Program
Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD
Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder
A Study to Assess the Effectiveness and Safety of Clonidine Extended-Release OnydaTM XR in Children With ADHD and ODD
Effects of LDX on Functioning of College Students With ADHD
Social Virtual-reality on Enhancing Social Interaction Skills in Children With Attention-deficit/Hyperactivity Disorder
A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder
Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
Effects of Subconcussive Head Impacts on Neural Integrity and Function in ADHD
Social VR Based Intervention on Enhancing Social Interaction Skills in Children With AD/HD